Previous hormone-replacement therapy (HRT) and anastrozole treatment appear to be major risk factors for developing joint symptoms

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1663, 2008-01, pp. : 21-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hormone replacement therapy (HRT) seems to reduce negative, but not positive, symptoms

By  

Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Cardiovascular Disease Risk and Hormone Replacement Therapy (HRT): A Review Based on Randomised, Controlled Studies in Postmenopausal Women

By  

Current Medicinal Chemistry, Vol. 7, Iss. 5, 2000-05 ,pp. : 499-517

Bentham Science Publishers

Access to resources Recommend Favorite

The use of hormone replacement therapy (HRT) is strongly associated with attitudes towards such therapy

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 437, 2003-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

The demise of HRT? The long-term safety of hormone replacement therapy

By Fenton Anna  

Expert Opinion on Drug Safety, Vol. 2, Iss. 4, 2003-07 ,pp. : 341-345

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy (HRT) with drospirenone offers the additional benefit of blood pressure reduction in postmenopausal women

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 2, 2008-02 ,pp. : 12-14

Adis International

Access to resources Recommend Favorite